Inotersen Interactions
There are 237 drugs known to interact with inotersen, along with 5 disease interactions. Of the total drug interactions, 183 are major, and 54 are moderate.
- View inotersen disease interactions (5)
Medications known to interact with inotersen
Note: Showing generic names only.
- abciximab
- acalabrutinib
- acyclovir
- adefovir
- ado-trastuzumab emtansine
- aldesleukin
- alteplase
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- anagrelide
- anisindione
- anistreplase
- antithrombin (recombinant)
- antithrombin iii
- apixaban
- ardeparin
- argatroban
- aspirin
- avapritinib
- bacitracin
- balsalazide
- bedaquiline
- betrixaban
- binimetinib
- bivalirudin
- black cohosh
- botulism immune globulin
- brentuximab
- bromfenac
- bromfenac ophthalmic
- cabozantinib
- cangrelor
- cannabidiol
- caplacizumab
- capreomycin
- carboplatin
- celecoxib
- cidofovir
- cilostazol
- cisplatin
- citalopram
- clofarabine
- clomipramine
- clopidogrel
- colistimethate
- cyclophosphamide
- cyclosporine
- cytomegalovirus immune globulin
- dabigatran
- daclizumab
- dalteparin
- danaparoid
- dasatinib
- deferasirox
- deferoxamine
- defibrotide
- deoxycholic acid
- desirudin
- desvenlafaxine
- dexfenfluramine
- diatrizoate
- diclofenac
- diclofenac ophthalmic
- diclofenac topical
- dicumarol
- diflunisal
- dimethyl fumarate
- dipyridamole
- diroximel fumarate
- drotrecogin alfa
- duloxetine
- edetate calcium disodium
- edetate disodium (edta)
- edoxaban
- efavirenz
- encorafenib
- enoxaparin
- entecavir
- epirubicin
- epoprostenol
- eptifibatide
- escitalopram
- etidronate
- etodolac
- everolimus
- exenatide
- fedratinib
- fenfluramine
- fenoprofen
- flucytosine
- fluoxetine
- flurbiprofen
- flurbiprofen ophthalmic
- fluvoxamine
- fondaparinux
- foscarnet
- ibandronate
- ibritumomab
- ibrutinib
- ibuprofen
- idelalisib
- ifosfamide
- iloprost
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- indomethacin
- interferon beta-1a
- interferon beta-1b
- iobenguane I 131
- iodamide
- iodine i 131 tositumomab
- iodipamide
- iodixanol
- iohexol
- iomeprol
- iopamidol
- iopromide
- iothalamate
- ioversol
- ioxaglate
- ioxilan
- leflunomide
- lepirudin
- levomilnacipran
- lifileucel
- lithium
- lomitapide
- lutetium lu 177 dotatate
- lutetium lu 177 vipivotide tetraxetan
- meclofenamate
- mefenamic acid
- meloxicam
- mesalamine
- methotrexate
- methoxyflurane
- metrizamide
- milnacipran
- mipomersen
- monomethyl fumarate
- moxetumomab pasudotox
- pamidronate
- panobinostat
- paroxetine
- peginterferon beta-1a
- pemetrexed
- penicillamine
- pentamidine
- pentosan polysulfate sodium
- pentoxifylline
- phenylbutazone
- piroxicam
- plazomicin
- plicamycin
- polymyxin b
- ponatinib
- prasugrel
- ramucirumab
- regorafenib
- remdesivir
- respiratory syncytial virus immune globulin
- reteplase
- rho (d) immune globulin
- rivaroxaban
- rofecoxib
- ruxolitinib
- salsalate
- sertraline
- sibutramine
- sirolimus
- streptokinase
- streptomycin
- streptozocin
- sulfasalazine
- sulfinpyrazone
- sulindac
- suprofen ophthalmic
- tacrolimus
- tazemetostat
- telavancin
- telbivudine
- temsirolimus
- tenecteplase
- tenofovir alafenamide
- tenofovir disoproxil
- teriflunomide
- thioguanine
- ticagrelor
- ticlopidine
- tinzaparin
- tipranavir
- tirofiban
- tobramycin
- tolmetin
- tositumomab
- tovorafenib
- trabectedin
- treprostinil
- turmeric
- valacyclovir
- valdecoxib
- valganciclovir
- vancomycin
- venlafaxine
- vilazodone
- voclosporin
- vorapaxar
- vortioxetine
Inotersen disease interactions
There are 5 disease interactions with inotersen which include:
Report options
More about inotersen
- inotersen consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous metabolic agents
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Vyndamax
Vyndamax may be given to reduce death or hospitalization caused by heart problems in adults with ...
Tegsedi
Tegsedi (inotersen) is an RNA-targeting treatment that may be used to reduce the symptoms of ...
Vyndaqel
Vyndaqel (tafamidis meglumine) is a transthyretin stabilizer that may be given to reduce death or ...
Onpattro
Onpattro is used to treat polyneuropathy in adults with hereditary transthyretin-mediated ...
Wainua
Wainua (eplontersen) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Eplontersen
Eplontersen (Wainua) is used to treat polyneuropathy of hereditary transthyretin-mediated ...
Vutrisiran
Vutrisiran is used to treat adults with nerve damage (polyneuropathy) caused by hereditary ...
Patisiran
Patisiran (brand name Onpattro) is an injectable treatment for polyneuropathy caused by hereditary ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.